282
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Metformin alleviates inflammation in oxazolone induced ulcerative colitis in rats: plausible role of sphingosine kinase 1/sphingosine 1 phosphate signaling pathway

, , ORCID Icon &
Pages 192-202 | Received 13 Jul 2020, Accepted 09 Jan 2021, Published online: 27 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Huan Lin, Haiyong Ao, Guanghua Guo & Mingzhuo Liu. (2023) The Role and Mechanism of Metformin in Inflammatory Diseases. Journal of Inflammation Research 16, pages 5545-5564.
Read now

Articles from other publishers (10)

Khaled Naja, Najeha Anwardeen, Moustafa Al-Hariri, Asmaa A. Al Thani & Mohamed A. Elrayess. (2023) Pharmacometabolomic Approach to Investigate the Response to Metformin in Patients with Type 2 Diabetes: A Cross-Sectional Study. Biomedicines 11:8, pages 2164.
Crossref
Fei Zou, Su Wang, Mengmeng Xu, Zengrong Wu & Feihong Deng. (2023) The role of sphingosine-1-phosphate in the gut mucosal microenvironment and inflammatory bowel diseases. Frontiers in Physiology 14.
Crossref
Xueliang Yi, Xuemei Tang, Tianlong Li, Lin Chen, Hongli He, Xiaoxiao Wu, Chunlin Xiang, Min Cao, Zixiang Wang, Yi Wang, Yiping Wang & Xiaobo Huang. (2023) Therapeutic potential of the sphingosine kinase 1 inhibitor, PF-543. Biomedicine & Pharmacotherapy 163, pages 114401.
Crossref
Kareman M. El-Beheiry, Magda El-Sayed El-Sayad, Thanaa A. El-Masry & Alaa E. Elsisi. (2023) Combination of metformin and hesperidin mitigates cyclophosphamide-induced hepatotoxicity. Emerging role of PPAR-γ/Nrf-2/NF-κB signaling pathway. International Immunopharmacology 117, pages 109891.
Crossref
Alaa Bagalagel, Reem Diri, Ahmad Noor, Deina Almasri, Hussain T. Bakhsh, Hussam I. Kutbi & Mohammed M. H. Al‐Gayyar. (2022) The therapeutic effects of cycloastragenol in ulcerative colitis by modulating SphK/MIP‐1α/miR‐143 signalling. Basic & Clinical Pharmacology & Toxicology 131:5, pages 406-419.
Crossref
Wasuwit Wanchaitanawong, Nithi Thinrungroj, Siriporn C. Chattipakorn, Nipon Chattipakorn & Krekwit Shinlapawittayatorn. (2022) Repurposing metformin as a potential treatment for inflammatory bowel disease: Evidence from cell to the clinic. International Immunopharmacology 112, pages 109230.
Crossref
Amin Hasanvand. (2022) The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases. Inflammopharmacology 30:3, pages 775-788.
Crossref
Nashwah G. M. Attallah, Suzy A. El-Sherbeni, Aya H. El-Kadem, Engy Elekhnawy, Thanaa A. El-Masry, Elshaymaa I. Elmongy, Najla Altwaijry & Walaa A. Negm. (2022) Elucidation of the Metabolite Profile of Yucca gigantea and Assessment of Its Cytotoxic, Antimicrobial, and Anti-Inflammatory Activities. Molecules 27:4, pages 1329.
Crossref
Moein Ala & Mahan Ala. (2021) Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?. ACS Pharmacology & Translational Science 4:6, pages 1747-1770.
Crossref
Mahmoud E. Youssef, Eslam E. Abd El-Fattah, Amir M. Abdelhamid, Hanan Eissa, Eman El-Ahwany, Noha A. Amin, Helal F. Hetta, Mohamed H. Mahmoud, Gaber El-Saber Batiha, Naglaa Gobba, Ahmed Gaafar Ahmed Gaafar & Sameh Saber. (2021) Interference With the AMPKα/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis. Frontiers in Pharmacology 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.